Resources

We calculated the human cost of the U.S. Global Gag Rule. The effects can be devastating for millions of poor and marginalised women.    WANT TO GET INVOLVED? SUBSCRIBE NOW TO GET UPDATES FROM IPPF SUPPORT OUR WORK WITH A DONATION

The purpose of this statement is to outline key components of the youth peer provision model, summarize existing evidence, and provide guidance to integrate this delivery approach into the existing sexual and reproductive health services offered by IPPF Member Associations.

Adama lost her best friend due to an unsafe abortion. This tragedy pushed her to work for and with young people to ensure them access to sexual and reproductive health information and services.   WANT TO GET INVOLVED?   SUBSCRIBE NOW TO GET UPDATES FROM IPPF SUPPORT OUR WORK WITH A DONATION

For over 60 years, IPPF has been at the vanguard of the family planning movement, championing and fighting for rights‑based, voluntary family planning worldwide. 

Abortion is an issue which people can have strong feelings about. Some consider it too ‘controversial' to include in education programmes. However, unplanned pregnancy and abortion are common occurrences around the world and IPPF believes that we all need accurate information to form our own values and make informed choices. This publication is a summary version of the peer education guide previously published.  

Sexual and reproductive health is related to multiple human rights, including the right to life, the right to health, the right to privacy and the prohibition of discrimination. The right to health include sexual and reproductive health. This means that the states have obligations to respect, protect and fulfil the rights related to women’s and men’s sexual and reproductive health.

During times of crisis sexual reproductive health services are a necessity.  Access to sexual and reproductive health services, even in the midst of war or natural disaster, is a human right which does not only saves lives in the short run, but also helps build resilience amongst refugees and displaced people.  The statistics of women affected in humanitarian crises are shocking. It is estimated that  more that 33 million of the 130 million people are in need of humanitarian assistance, are women and adolescent girls of reproductive age - 500 of these women and girls die every day from complications related to pregnancy and childbirths. WANT TO GET INVOLVED? SUBSCRIBE NOW TO GET UPDATES FROM IPPF SUPPORT OUR WORK WITH A DONATION

Profound changes in demographic patterns are taking place globally. Birth rates are falling in most countries around the world. Many governments are concerned about the impact of population ageing, and its consequent effects on lower economic productivity and escalating costs for medical care for older people. Some argue that birth rates must be stimulated to increase again. A few have begun to question the legitimacy of contraception and parenthood by choice, as well as challenging the principle of gender equality. This concern may also result in reduced focus on ‘the other side of the story’, namely that 225 million women who wish to avoid or delay pregnancy are not using modern contraception. Such restrictive approaches contravene people’s right to “reproduce and the freedom to decide if, when and how often to do so” as agreed at the 1994 International Conference on Population and Development, and reiterated through the 2015 Sustainable Development Goals.

Cervical cancer, largely preventable, is one of the main causes of cancer death in women. In 2012, 528,000 new cases of cervical cancer were diagnosed and 266,000 women died of the disease, nearly 90 per cent of them in low to middle income countries. Deaths due to cervical cancer are projected to rise by almost 25 per cent over the next 10 years.1 Most women die of the disease when they are still in the workplace and caring for their families, at a high cost to society and to the economy. Cervical cancer prevention encompasses a wide range of interventions, which provide IPPF Member Associations with multiple opportunities within the continuum of care to decrease mortality and morbidity from the disease.

Research involving human subjects – including the study of human reproductive tissues, cells and fluids – has been and will continue to be essential for scientific advancement. For example, organ biopsies (such as cervix, ovary, uterus, testes, prostate, placenta and so on), cell lines developed and maintained in laboratories derived from both normal and abnormal reproductive tissues, and sampling of reproductive fluids (such as semen, cervical mucus, uterine and amniotic fluid) have contributed to both the understanding of normal reproductive physiology and pregnancy as well as the pathogenesis of disease. Modern contraceptive methods, the human papillomavirus vaccine, the Papanicolaou test, amniocentesis, regimens for the treatment of reproductive cancers and advanced reproductive technologies for infertility are examples of the diverse preventive, diagnostic and therapeutic innovations resulting from studies of human reproductive tissues.